Eyelash extensions may cause ocular disorders

Article

Ocular disorders such as keratoconjunctivitis and allergic blepharitis can be caused by wearing eyelash extensions.

Ocular disorders such as keratoconjunctivitis and allergic blepharitis can be caused by wearing eyelash extensions, reports a new study in the journal Cornea.

The retrospective investigation, compiled by Dr Yuki Amano and his team, Department of Ophthalmology, University of Tokyo, Graduate School of Medicine, Japan, involved 107 female patients with ocular complaints caused by eyelash extensions. Each patient had visited ophthalmologic clinics between March 2007 and March 2010. None of the patients had a history of eye disease and were aged between 21 years and 60 years.

The findings revealed that ocular disorders keratoconjunctivitis caused by invasion of glue or removing agents occurred in 64 patients. A further 42 patients experienced allergic blepharitis caused by eyelash extension glues.

Three patients presented with conjunctival erosion due to eyelid-fixing tapes, 1 patient had allergic blepharitis due to eyelid-fixing tapes and 1 patient experienced subconjunctival haemorrhage due to compression during eyelash extension removal.

Eye drops and ointments were used to treat all patients and the eyelash extension glue ingredient that caused the most ocular damage was formaldehyde.

The study suggests that the ingredients of eyelash glue should be improved, along with the ophthalmologic knowledge of physicians.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
At this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah, Nitish Mehta, MD, shared highlights from his research documenting real-world results of aflibercept 8 mg for patients with diabetic macular oedema.
ARVO 2025: Anat Loewenstein, MD, shares data from herself and her colleagues on meeting needs of patients with diabetic retinopathy
At the American Society of Cataract and Refractive Surgeons annual meeting, Sheng Lim, MD, FRCOphth discusses the benefit of endoscopic cyclophotocoagulation for patients with primary open angle glaucoma and cataracts in the CONCEPT study
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
© 2025 MJH Life Sciences

All rights reserved.